Skip to main content
NEWLAND PHARMACEUTICAL CO., LTD logo

NEWLAND PHARMACEUTICAL CO., LTD — Investor Relations & Filings

Ticker · 301277 ISIN · CNE1000065K2 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 481 across all filing types
Latest filing 2025-04-21 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 301277

About NEWLAND PHARMACEUTICAL CO., LTD

https://www.newlandpharma.com

Newland Pharmaceutical Co., Ltd. is a specialized enterprise engaged in the research, development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs) and high-quality chemical intermediates. The company focuses on a broad spectrum of therapeutic categories, including cardiovascular, anti-infective, and metabolic health solutions. Operating with a commitment to rigorous quality control, its production facilities are designed to meet international Good Manufacturing Practice (GMP) standards. Newland Pharmaceutical prioritizes technological innovation and chemical synthesis optimization to deliver reliable pharmaceutical components. Its core operations involve the large-scale production of complex molecules, supporting the supply chains of healthcare providers and pharmaceutical formulators worldwide through a focus on technical excellence and regulatory compliance.

Recent filings

Filing Released Lang Actions
2025年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2025 年第一季度报告" which translates to "2025 First Quarter Report." It contains detailed financial data including income, net profit, cash flow, assets, liabilities, and shareholder information for the first quarter of 2025. The presence of comprehensive financial statements such as the consolidated balance sheet and detailed financial metrics confirms this is a quarterly financial report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2025
2025-04-21 Chinese
关于召开2025年第一次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2025 first extraordinary general meeting (临时股东会) of shareholders for 新天地药业股份有限公司. It includes information about the meeting date, voting procedures (both onsite and online), registration details, agenda items, and proxy forms. There is no financial data or report content, but rather an announcement and instructions related to the shareholder meeting. This fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is over 5,000 characters and contains detailed meeting and voting information, not just a brief announcement or a report publication notice. Therefore, the best classification is PSI.
2025-04-21 Chinese
华泰联合证券有限责任公司关于新天地药业股份有限公司部分募集资金投资项目结项并将节余募集资金永久补充流动资金及注销募集资金专户的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from the sponsor institution (华泰联合证券有限责任公司) regarding the completion of certain fundraising investment projects by 新天地药业股份有限公司 and the permanent supplementation of surplus raised funds into working capital, as well as the cancellation of the fundraising special account. It references regulatory guidelines, fundraising amounts, project investment plans, usage and surplus of raised funds, approvals by the board, supervisory board, and shareholders, and the sponsor's verification opinion. The document is not a full annual or interim financial report, nor is it a simple announcement. It is a formal audit or verification report related to the use and management of raised funds, consistent with an Audit Report / Information (AR) filing. The length (5462 characters) and content confirm it is a substantive report, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. Q1 2025
2025-04-21 Chinese
关于2025年第一季度报告披露的提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (293 characters) stating that the company's 2025 first quarter report has been disclosed on an official website. It does not contain the actual financial data or detailed report content but merely informs investors about the report's availability. According to the 'MENU VS MEAL' rule, such a brief notice about report disclosure is classified as a Report Publication Announcement (RPA), not the report itself (IR).
2025-04-21 Chinese
关于变更董事会秘书兼证券事务代表的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding a change in the company's board secretary and securities affairs representative. It details the resignation of the previous secretary and the appointment of a new one, including the new appointee's qualifications and relationships. There are no financial statements, earnings data, or detailed reports. The content fits the category of Board/Management Information, as it concerns changes in senior management roles within the company.
2025-04-21 Chinese
董事会提名委员会关于聘任高级管理人员的审查意见
Board/Management Information Classification · 100% confidence The document is a formal opinion from the Board Nomination Committee regarding the change of the company's Board Secretary and Securities Affairs Representative. It references company laws, stock exchange listing rules, and internal company regulations. The content focuses on management appointment and qualifications, with no financial data or report content. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2025-04-21 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.